Bill Detail
H.R. 2214
Congress: 119
Title
DRUG Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Mariannette Miller-Meeks [R-IA-1]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Jun 29, 5:09 AM · synced 15h ago
Introduced
2025-03-18
Data source mode: cache
Bill Engagement
DRUG Act
Sponsor
Rep. Mariannette Miller-Meeks [R-IA-1]R
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
4D · 2R
Bipartisan
LDA engagement
6 orgs · 10 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2025-03-18
Lobbyists on the case
6 orgs · 70 lobbyists · 10 filings mention H.R. 2214 (DRUG Act) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America5 filings · 28 lobs
- Johnson & Johnson Services, Inc.1 filing · 16 lobs
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
- Cvs Health (and Subsidiaries)1 filing · 7 lobs
- Todd Strategy Group1 filing · 4 lobs
- Roberti Global (F/k/a Roberti White, LLC)1 filing · 3 lobs
Lobbyists on this bill
- Teresa Bill2026 Q1
- Elenora Connors2026 Q1
- Catherine Douglas2026 Q1
- Bart Forsyth2026 Q1
- Jake Freed2026 Q1Pharmaceutical Research and Manufacturers of America · Cong. Affairs Specialist - FDA; Leg. Asst., Leg. Aide/Press Asst., Staff Asst., District Field Re…
- Kelly Goldberg2026 Q1
- Judith Haron2026 Q1
- Lauren Jee2026 Q1
+ 62 more